She serves in several leadership roles connected to her academic interests. For instance, she is on the Society for Neuroscience Upper Midwest Chapter’s Board of Counselors, for which she votes on decisions and leads science communication training and outreach initiatives. She also serves on the Lived Experience Council for One Mind, a global organization that evaluates proposals for neuropsychiatric research and advises principal investigator awardees on how to incorporate lived experience perspectives into studies.
“I am a champion for including people with lived experience in decision-making and research and for taking this into consideration when deciding what research is important,” Chatterjee explains. “Lived experience in research is commonly funded in the United Kingdom, but not as much in the United States.”
Chatterjee’s second and third years of graduate school were supported by a fellowship in the TL1 Training Program offered by the UW–Madison Institute for Clinical and Translational Research and NIH. In the fellowship, Chatterjee’s work reflected her extensive lived experience-informed science communication and advocacy. For instance, her podcast, A Chat with Uma, reaches thousands in 125 countries (available on all podcast platforms). Her science communication also has earned prestigious recognition, including the Society for Neuroscience’s Next Generation Award in October 2026 and the Museum of Science’s Digital Science Communication Fellowship.
Further, Chatterjee has been a global advocate for the International OCD Foundation and serves on the Research Proposal Review Committee for the foundation’s annual conference. She previously served as president of OCD Wisconsin, the state-level IOCDF initiative.
Her advisor, Michael Cahill, PhD, an associate professor of comparative biosciences in the UW School of Veterinary Medicine, took Chatterjee on as a graduate student after she approached him about applying the questions he asks in his laboratory about disorders such as schizophrenia, bipolar disorder, and autism spectrum disorder, to OCD.
“I credit him for being a transformative, empowering mentor, which requires a significant investment of his time and trust,” Chatterjee says.
Cahill helped Chatterjee procure, from the NIH Human Brain Collection Core, human postmortem tissue from a cohort of people with OCD.
“We are conducting the first-known OCD protein quantification studies in the human brain,” Chatterjee says.
Cahill adds, “Uma has an unparalleled ability to bridge her personal life experiences and scientific outreach endeavors with her laboratory-based research. This is highlighted by her ability to obtain human brain samples from understudied neuropsychiatric conditions, with the hope of identifying key molecular targets in the underlying disease pathophysiology.”
Ruprecht’s Commitment
Ruprecht is a 2026-27 member of the American Medical Association (AMA) Board of Trustees, which entails attending board meetings, contributing to reports, and participating in discussions and the implementation of advisory groups, including a new group on digital health and artificial intelligence.
“The board is full of impressive, distinguished physicians,” says Ruprecht. “I am proud to have a voice in that room and be able to share the perspective of a medical student.”
Her AMA board mentor is Ilse Levin, DO, MPH, TM, an internist and epidemiologist in Maryland. Ruprecht says all board members value her perspective.
Ruprecht recently shared feedback on a new AMA communications campaign encouraging patients to invest their trust in their physicians’ expertise.
She also has visited medical students around the country, including recently at the University of Colorado.
“We talked with the Colorado Medical Society about its sponsorship of medical student memberships and potentially transitioning to an automatic system so all students would get the benefits of AMA membership,” she says.